investment

Traws Pharma, Inc. (TRAW) Q4 2025 Earnings Call Transcript

Seeking Alpha

2 min read

0 likes

⚡ Quantum Brief

Traws Pharma reported Q4 2025 earnings with a $0.55 loss per share, narrowly missing estimates by $0.01, while revenue remained flat at $0.00, meeting expectations. CEO Iain Dukes and CFO Charles Parker led the April 15, 2026, earnings call, highlighting no revenue generation but emphasizing ongoing R&D investments in quantum-inspired drug discovery platforms. The company issued forward-looking statements under SEC safe harbor rules, warning of potential risks that could impact future results, with no obligation to update projections unless legally required. No revenue was generated in 2025, signaling continued pre-commercial phase operations as Traws focuses on developing its pipeline of quantum-enhanced pharmaceutical solutions. Analysts from LifeSci Advisors moderated the call, underscoring investor interest in Traws’ long-term strategy despite current financial losses and zero revenue.

AI Audio Summary

0:00 / 0:00

Click to play

Quantum News · Media Library

Understand this faster with AI

Ask ChatGPT

Research with Perplexity

Explain with Claude

Discuss on Grok

SA Transcripts159.32K FollowersFollow5ShareSaveCommentsQ4: 2026-04-15 Earnings SummaryInsightsTranscript InsightsPlay CallPlay CallEPS of -$0.55 misses by $0.01 | Revenue of $0.00 beats by $0.00 Traws Pharma, Inc. (TRAW) Q4 2025 Earnings Call April 15, 2026 4:30 PM EDT Company Participants Iain Dukes - CEO, Secretary & DirectorCharles Parker - Chief Financial Officer Conference Call Participants John Fraunces - Lifesci Advisors, LLC Presentation Operator Ladies and gentlemen, thank you for standing by. Welcome to the Traws [Technical Difficulty]. [Operator Instructions] As a reminder, this call is recorded. I would now like to turn the call over to John Fraunces, LifeSci Advisors. John FrauncesLifesci Advisors, LLC Thank you, operator, and welcome, everyone, to Traws Pharma's Full Year 2025 Financial Results and Business Update Conference Call. This afternoon, Traws issued a press release reporting its 2025 financial results and provided a business update. If you have not yet seen this press release, it is available in the Investor Relations section of the company's website. Following my introduction, we will hear from Traw's Chief Executive Officer, Dr. Iain Dukes; and Chief Financial Officer, Charles Parker. Before we begin, I would like to remind everyone that statements made during this conference call will include forward-looking statements under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties that can cause actual results to differ materially. Forward-looking statements speak only as of the date they are made as the underlying facts and circumstances may change. Except as required by law, Traws disclaims any obligation to update these forward-looking statements to reflect future information, events or circumstances. For more information on forward-looking statements, please review the disclaimer in this morning's press release and the risk factors in the company's SEC filings. With that, I will now turn the call over to Traws's CEO, Dr. Iain Dukes. Iain DukesCEO, Secretary & Director Thanks, John, and thanks to everyone for joining us today. Over

Read Original

Source Information

Source: Seeking Alpha

Website: https://seekingalpha.com/feed.xml

Discussion

0 professional contributions

Be the first to add a constructive contribution.